Personalized immune cells target Tough-to-Treat lymphoma
Disease control
Terminated
This study tested a personalized cell therapy called AUTO4 for adults with specific types of T-cell lymphoma that had returned or stopped responding to standard treatments. Doctors collected a patient's own immune cells, engineered them in a lab to better target the cancer, and t…
Phase: PHASE1, PHASE2 • Sponsor: Autolus Limited • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC